| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |